Protein biomarker identification in the CSF of patients with CNS lymphoma. - Wikidata - wikimedia - TriplyDB

Protein biomarker identification in the CSF of patients with CNS lymphoma.

Protein biomarker identification in the CSF of patients with CNS lymphoma.

http://www.wikidata.org/entity/Q33308477

about

Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies A systematic approach to the diagnosis of suspected central nervous system lymphoma.How to facilitate early diagnosis of CNS involvement in malignant lymphoma.Biology and treatment of primary central nervous system lymphoma.In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.Progress in central nervous system lymphomas.Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment Insights into the biology of primary central nervous system lymphoma Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid Metaprotein expression modeling for label-free quantitative proteomics.Recent developments in quantitative proteomics.Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.Application of proteomics to cancer early detection Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis.The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma New approaches in primary central nervous system lymphoma.How I treat CNS lymphomas.Large-scale multiplexed quantitative discovery proteomics enabled by the use of an (18)O-labeled "universal" reference sample New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.What's positive about 'triple-negative' breast cancer?Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma.Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.

P2860

Q26774431-8793A7A6-869A-45A2-8AB5-7F83F8BA1C1B Q30586022-C6FCC857-78DD-4FFC-AF93-BCC9F10988CB Q31133442-365305BF-C377-4537-95C6-1F4EDE369164 Q33475480-8985484E-1BA7-41E0-A172-B09F4970D57C Q33525762-177DE001-7AE1-480F-91F7-5529B084D9D5 Q33805149-0133FA14-F56A-4353-A995-4B9F99255A93 Q33934406-5516191C-40EB-4389-BC3F-B21E9FDBF239 Q33946604-E5A277F4-EA45-4F47-8EFC-FD22E2AD7F55 Q33946618-162F1060-E0C3-40B6-A97C-264C34C39450 Q34072931-C2FEE321-EE27-4CF9-9045-36EA891D724A Q34174899-DFE251D4-A481-4E37-A0A7-70373CBAAE81 Q34228023-137F5C54-6997-4551-B651-940BB41571B4 Q34258606-BEAFDA2E-DD56-4B19-9FDD-AE34934947E8 Q34307294-3891B2FB-2EF0-4491-85A1-530E3B587A56 Q34490428-41B84344-98A3-425F-8C07-74F6F0D0E490 Q35053031-0DAAD664-E487-4E55-80FA-2B1A45F7F5E2 Q35213832-0E3A88B0-93E8-4DE8-AE6B-820F36358E2B Q35599811-02FD0FB5-DDD2-447C-A99C-2913BF6C75E6 Q35607611-82E79897-BEB0-4A39-AB8A-F360858C7550 Q35760627-647F1CD5-4564-41DF-9730-1229E58DB58B Q35946342-371D7B27-97F2-421B-83DE-546478DF3B67 Q36037594-7EF03479-8F23-44DF-8A0E-DAFF589B7DF8 Q36288275-3BB8ACC6-F72B-4FEA-BFEE-495D858D7A64 Q36302956-32DC6E74-50CC-4A1A-8863-FCCBF9BD0245 Q36463751-93D798D0-955C-418D-BFDE-FB0C93311B46 Q36576972-85684110-87EA-4B05-8D95-9970D5928BEF Q36907849-5FF2BA99-FFBF-4EBC-916A-F2175DF31E05 Q37088471-172D0517-1F25-445C-8338-1B65BB85D5FE Q37215118-10AD105A-78CA-433D-89D6-D352C8747EE3 Q37363281-930AF50D-19AD-409D-B516-B66275280C65 Q37577541-5C3FAA6D-DE56-4203-9176-0E291503724C Q37605859-4D81ED99-82D5-4C77-A267-CE78BC157ADD Q37618814-3E99F659-97D2-4C2A-8365-59F207A85209 Q37620923-AAEDA11D-E01E-4833-A991-A94E665ED632 Q37690311-ECA6C273-43F1-4F4A-97EA-9942DAC1913C Q37691267-374DDE04-4384-4003-ACDF-8C5CA3A6E928 Q38207538-1540D515-49E2-499C-858A-97B91D558C53 Q38233150-65727C3B-D3E4-4FA8-B8BD-BD50077BA13F Q38287712-F212A5B7-EFBC-47BD-A623-69434B485FD9 Q38702839-EE2F3213-8BC5-44DE-8CA5-0D6B821435D1

P2860

Protein biomarker identification in the CSF of patients with CNS lymphoma.

http://www.wikidata.org/entity/Q33308477

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@ast

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@en

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@nl

type

label

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@ast

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@en

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@nl

prefLabel

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@ast

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@en

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@nl

P1433

Q33308477-9C79C56D-B133-4A28-9D53-47D6AE5C3E86

P1476

Q33308477-E806C42E-90B3-4E31-9119-2DC95DA6282C

P2093

Q33308477-0FF2C858-2510-489C-BDEB-FF01E49A1B0F

Q33308477-3C257BCC-D079-49B9-BA9B-B0E10B7B0BB2

Q33308477-4C188088-CDB5-4B9F-ABF7-C789B99AEBB3

Q33308477-7A33EDA7-78C1-4558-9ED7-3952C8DA90E0

Q33308477-7D18536C-CE4D-45FA-A991-29873C6AE11A

Q33308477-86213CE4-C712-43D7-800A-ED762605201B

Q33308477-9A941515-5BB0-4170-BDE8-79A09E86BE5B

Q33308477-A4B371AD-BD35-42CD-BAA1-D2D6CC834EC2

Q33308477-A6CF9790-64CF-41E1-AFB1-B539A0524EA1

Q33308477-ACEEF97E-B06A-494E-911A-B873B885BC7F

P2860

Q33308477-01D0B380-0602-4914-B184-426DF612ED80

Q33308477-0679829B-9541-493C-A7AE-EFDDC40E25CC

Q33308477-0888ECC9-9880-4DDA-B6B0-667FBB8F589C

Q33308477-0AF0D26D-0368-416A-8E9B-B07825DE8326

Q33308477-2F0C2733-0270-43A0-B14B-3B191EA5FE9D

Q33308477-2FC74A8E-865E-4168-A6F7-3F188661E5EB

Q33308477-336914A1-E2D1-43BB-BD4B-28F823088FAD

Q33308477-43AFD120-A794-424A-BBFF-FB0DF2B189D1

Q33308477-4C757DFC-6FAE-4BAD-84E7-0148A73A72C0

Q33308477-870CCD42-0325-468E-B10F-48A9DD206154

P304

Q33308477-C4227B43-9A4D-4D72-8350-C1CC42A925EB

P31

Q33308477-DBA4617E-8870-41E2-8B9D-7880ACC56BB3

P356

Q33308477-526638ED-4CE7-4EA5-AE56-569E8D07B365

P407

Q33308477-4717139B-2DD8-4DFA-B241-08EF8A75182F

P433

Q33308477-5408DA66-1BCB-412E-B714-25643985FFC3

P478

Q33308477-081EA54A-FE7A-468D-A1FA-CF7129AEBD38

P577

Q33308477-9931BF87-EAC1-4AC1-9D8F-1AC09AF4F929

P698

Q33308477-33E11B3B-57FB-442A-BE2C-EE5753CBC4EC

P921

Q33308477-3028C1A2-3918-4A4B-83F5-26A01A332E8C

Q33308477-5CC8E9D7-FFC8-47DD-8C13-36CF17377546

P932

Q33308477-D8FBC453-8E5F-45F8-9562-0CD7AF19D7CB

P356

JCO.2007.12.1053

P1433

Journal of Clinical Oncology

P1476

Protein biomarker identification in the CSF of patients with CNS lymphoma.

@en

P2093

Christopher H Becker

http://www.w3.org/2001/XMLSchema#string

Cigall Kadoch

http://www.w3.org/2001/XMLSchema#string

Howard Schulman

http://www.w3.org/2001/XMLSchema#string

James L Rubenstein

http://www.w3.org/2001/XMLSchema#string

Jane Fridlyand

http://www.w3.org/2001/XMLSchema#string

Jon Karch

http://www.w3.org/2001/XMLSchema#string

Juliana Karrim

http://www.w3.org/2001/XMLSchema#string

Lloyd Damon

http://www.w3.org/2001/XMLSchema#string

Marc A Shuman

http://www.w3.org/2001/XMLSchema#string

Patrick Treseler

http://www.w3.org/2001/XMLSchema#string

P2860

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments.

Use of proteomic patterns in serum to identify ovarian cancer.

MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.

Neoplastic meningitis: a guide to diagnosis and treatment.

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Mechanisms of serpin dysfunction in disease.

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

P304

96-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.12.1053

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18056677

http://www.w3.org/2001/XMLSchema#string

P921

P932

4134101

http://www.w3.org/2001/XMLSchema#string